Fall 2023 issue of quarterly NFID eNewsletter covering:
- NFID National Survey: Attitudes about Respiratory Diseases
- 2023 Annual News Conference
- Online Clinical Vaccinology Course
- 50th Anniversary Gala Recap
- NFID Resources (Videos, Webinars, Podcasts, Blogs)
- More …
Message From Headquarters
For the first time ever, vaccines and preventive monoclonal antibodies are available to help protect against 3 major respiratory viruses: influenza (flu), COVID-19, and respiratory syncytial virus (RSV). Despite that good news, data from a new National Foundation for Infectious Diseases (NFID) survey of US adults found that fewer than 1 in 4 US adults are concerned about getting infected with these viruses, and 43% do not plan to, or are unsure if they will get vaccinated against flu. Only 40% plan to get an updated COVID-19 vaccine, and only 40% of adults age 60 years and older plan to get vaccinated against RSV …
Related Posts
October 1, 2024
The Double Helix, Fall 2024
Quarterly eNewsletter covering: Respiratory Disease Prevention This Fall and Winter, Strategies to Improve Adult Immunization, Awards Gala Recap, Clinical Vaccinology Course, NFID Resources (Videos, Webinars, Podcasts, Blogs), and more …
June 28, 2024
The Double Helix, Summer 2024
Quarterly eNewsletter covering: NFID Spanish Website, Increasing US Vaccine Uptake, Adult Immunization Rates, Bird Flu Updates, Upcoming NFID Events, Resources (Webinars, Podcasts, Blogs), Partner Spotlight, and more …
March 29, 2024
The Double Helix, Spring 2024
Quarterly eNewsletter covering: Measles, Vaccine Access, 2024 Annual Conference on Vaccinology Research, Partner Spotlight, and more …